Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
31	Strides Pharma Science Ltd.	Q V+ PT	9,855 Small Cap	1,069.15 (-2.57%)	15.98	2.88	7.94	21.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,009 (0.55%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Krsnaa Diagnostics Ltd.	Q V+ PT	1,635 Small Cap	504.10 (0.93%)	16.78	1.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,204.40 (0.46%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	FDC Ltd.	Q V PT	6,132 Small Cap	376.65 (-0.13%)	19.53	2.29	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Ambalal Sarabhai Enterprises Ltd.	Q V PT	268 Small Cap	35 (0.00%)	19.79	1.66	4.33	3.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	3B Blackbio Dx Ltd.	Q V PT	1,113 Small Cap	1,296.25 (-4.65%)	20.04	3.34	-8.95	-14.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Fermenta Biotech Ltd.	Q V PT	1,229 Small Cap	417.55 (-5.05%)	20.32	2.98	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Aarti Drugs Ltd.	Q V PT	3,977 Small Cap	435.70 (-2.95%)	20.8	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Syncom Formulations (India) Ltd.	Q V+ PT	1,810 Small Cap	19.25 (-5.54%)	21.16	4.11	21.49	39.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Themis Medicare Ltd.	Q V PT	875 Small Cap	95 (-2.56%)	21.89	2.08	8.21	-69.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Alembic Pharmaceuticals Ltd.	Q V+ PT	15,682 Small Cap	797.80 (0.33%)	22.61	2.68	6.37	-8.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Eris Lifesciences Ltd.	Q V+ PT	16,088 Small Cap	1,159.60 (-0.35%)	22.74	3.88	20.89	11.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Pfizer Ltd.	Q V PT	16,867 Small Cap	3,687.05 (-1.95%)	22.94	3.83	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	GPT Healthcare Ltd.	Q V PT	1,089 Small Cap	132.70 (-2.61%)	23.04	3.86	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Kilitch Drugs (India) Ltd.	Q V PT	703 Small Cap	201 (-3.69%)	23.38	2.5	28.00	58.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,808.45 (-1.45%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,217 Small Cap	177.75 (-3.84%)	25.68	2.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Alivus Life Sciences Ltd.	Q V+ PT	17,311 Small Cap	1,407.80 (0.72%)	25.85	4.77	6.24	6.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,324.85 (-2.05%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Amrutanjan Health Care Ltd.	Q V+ PT	1,436 Small Cap	496.85 (0.70%)	26.61	3.83	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	306.65 (-2.68%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	484.85 (-6.88%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	877.25 (-5.00%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,244 (4.89%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,551.05 (-1.86%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,125 (1.49%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Advanced Enzyme Technologies Ltd.	Q V+ PT	2,944 Small Cap	262.95 (-0.55%)	29.56	4.15	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Gaudium IVF and Women Health Ltd.	Q V PT	770 Small Cap	105.75 (-4.69%)	31.47	5	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Laxmi Dental Ltd.	Q V PT	978 Small Cap	177.75 (-0.22%)	31.67	3.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Nov, 2026

Advanced Enzyme Tech - Quaterly Results

The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1371.68	1157.48	18.51	2530.25	2407.72	5.09	4527.66	3514.11	28.84
Other Income	163.97	30.79	432.54	186.84	569.31	-67.18	633.88	614.90	3.09
PBIDT	543.16	326.70	66.26	870.15	1170.48	-25.66	1738.22	1321.69	31.51
Interest	0.31	0.49	-36.73	0.68	1.02	-33.33	2.07	2.36	-12.29
PBDT	542.85	326.21	66.41	869.47	1169.46	-25.65	1697.57	1319.33	28.67
Depreciation	31.73	30.02	5.70	60.94	59.31	2.75	120.83	114.05	5.94
PBT	511.12	296.19	72.56	808.53	1110.15	-27.17	1576.74	1205.28	30.82
TAX	94.07	73.37	28.21	168.02	147.52	13.90	258.68	181.08	42.85
Deferred Tax	1.25	0.54	131.48	8.56	0.28	2957.14	-12.01	12.22	-198.28
PAT	417.05	222.82	87.17	640.51	962.63	-33.46	1318.06	1024.20	28.69
Equity	220.53	223.76	-1.44	223.95	223.76	0.08	223.85	223.76	0.04
PBIDTM(%)	39.60	28.23	40.29	34.39	48.61	-29.26	38.39	37.61	2.07

Oct, 2026

Advanced Enzyme Technologies informs about outcome of board meeting

Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Alembic Pharmaceuticals gets USFDA’s final nod for Venetoclax Tablets

Alembic has a cumulative total of 248 ANDA approvals from the USFDA

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Strides Pharma Science informs about analyst meet outcome

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed that the audio recording of the Earnings Call held for investors and analysts today, Friday, October 30, 2026, at 10:00 hrs IST, to discuss Company’s unaudited financial results for the quarter and half year ended September 30, 2026, has been made available on the Company’s website at: https://www.strides.com/investors/financial-performance/quarterly-results

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sanofi Consumer Healthcare India Ltd.	7,911 Crore
2	Evonile Pharma Ltd.	4,182 Crore
3	Suven Life Sciences Ltd.	7,293 Crore
4	KMC Speciality Hospitals (India) Ltd.	2,422 Crore
5	Dr Agarwals Eye Hospital Ltd.	2,552 Crore
6	Gujarat Themis Biosyn Ltd.	4,718 Crore
7	Medico Remedies Ltd.	155 Crore
8	Procter & Gamble Health Ltd.	9,436 Crore
9	Onesource Specialty Pharma Ltd.	17,926 Crore
10	Piramal Pharma Ltd.	31,826 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Advanced Enzyme Tech - Quaterly Results

Advanced Enzyme Technologies informs about outcome of board meeting

Alembic Pharmaceuticals gets USFDA’s final nod for Venetoclax Tablets

Vimta Labs - Quaterly Results

Strides Pharma Science informs about analyst meet outcome

Vimta Labs informs about unaudited financial results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?